» Articles » PMID: 6723754

Correlation Between the Pharmacokinetics and Pharmacodynamics of Dopamine in Healthy Subjects

Overview
Specialty Pharmacology
Date 1984 Jan 1
PMID 6723754
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics and the pharmacodynamic action of dopamine were investigated in 5 healthy subjects. Dopamine was given in different doses (200, 400 and 800 micrograms/min) by constant intravenous infusion over 90 min. In order to control the influence of the procedure on the measured parameters the subjects also received a similar infusion of saline. Dopamine, noradrenaline and adrenaline levels in plasma were followed for up to 6 h after the infusion, and arterial pressure and heart rate were monitored. Dopamine reached a steady state level within 15 to 30 min after commencement of the infusion; the steady state levels averaged 36.5 micrograms/l at 200 micrograms/min, 73.8 micrograms/l at 400 micrograms/min and 207 micrograms/l at 800 micrograms/min. The corresponding total clearances were 5.81/ min, 5.51/min and 3.91/min suggesting non-linear kinetics. The kinetics could not be described by compartmental model. Noradrenaline and adrenaline levels were found to be elevated during infusion of dopamine. Noradrenaline had returned to its pretreatment level within 15 to 30 min after cessation of the infusion, whereas the adrenaline level did not return to the pretreatment value within the observation period. Heart rate was increased by the dose of 400 micrograms/min, and the systolic and mean arterial pressures were elevated, whereas distolic blood pressure remained unchanged. Elevated systolic blood pressure was better correlated with plasma dopamine than with noradrenaline concentration.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Pharmacokinetics and pharmacodynamics of intravenous inotropic agents.

Lehtonen L, Antila S, Pentikainen P Clin Pharmacokinet. 2004; 43(3):187-203.

PMID: 14871156 DOI: 10.2165/00003088-200443030-00003.


Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients.

Johnston A, Steiner L, OConnell M, Chatfield D, Gupta A, Menon D Intensive Care Med. 2003; 30(1):45-50.

PMID: 14586494 DOI: 10.1007/s00134-003-2032-4.


Studies on the pharmacological control of gastric emptying in man.

Bateman D Br J Clin Pharmacol. 1985; 20(4):339-44.

PMID: 3841005 PMC: 1400888. DOI: 10.1111/j.1365-2125.1985.tb05074.x.


Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Henwood J, Todd P Drugs. 1988; 36(1):11-31.

PMID: 3063492 DOI: 10.2165/00003495-198836010-00003.


Effects of dopamine infusion on plasma catecholamines in preterm and term newborn infants.

Stopfkuchen H, Racke K, Schworer H, Queisser-Luft A, Vogel K Eur J Pediatr. 1991; 150(7):503-6.

PMID: 1915503 DOI: 10.1007/BF01958433.

References
1.
Engelman K, Portnoy B . A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels. Circ Res. 1970; 26(1):53-7. DOI: 10.1161/01.res.26.1.53. View

2.
Rosenblum R, TAI A, Lawson D . Dopamine in man: cardiorenal hemodynamics in normotensive patients with heart disease. J Pharmacol Exp Ther. 1972; 183(2):256-63. View

3.
MCDONALD Jr R, Goldberg L, MCNAY J, TUTTLE Jr E . EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. J Clin Invest. 1964; 43:1116-24. PMC: 289593. DOI: 10.1172/JCI104996. View

4.
Holzer J, Karliner J, ORourke R, Pitt W, ROSS Jr J . Effectiveness of dopamine in patients with cardiogenic shock. Am J Cardiol. 1973; 32(1):79-84. DOI: 10.1016/s0002-9149(73)80088-8. View

5.
Heinzel G, Hammer R, Wolf M, KOSS F, Bozler G . [Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)]. Arzneimittelforschung. 1977; 27(4a):904-11. View